Lastly, in agreement with our data showing STING loss is associated with resistance to DNA damage, analysis of a cohort of patients with head and neck squamous cell carcinoma shows that low tumor STING expression is associated with worse oncologic outcomes. This evidence concerns the gene STING1 and neoplasm.